
|Articles|September 6, 2013
VIDEO: Avoidable Costs in U.S. Healthcare
Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."
Advertisement
Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Pharmacy Technician Shines Light on Expanding Role
4
How Pharmacists Can Address Measles Misinformation with Patients
5






































